| |
fiscal year 1995-96, the sum may not exceed $182,000,000; and for | fiscal year 1996-97, the sum may not exceed $190,000,000 | | $100,000,000. |
|
| | | Sec. A-2. Appropriation. The following funds are appropriated from | | the General Fund to carry out the purposes of this Part. |
|
| | | Provides funds to meet the debt | | service payments related to a | | $100,000,000 tax anticipation | | note authority for fiscal year | | 2001-02. |
|
| | | Sec. B-1. 22 MRSA §258, sub-§8 is enacted to read: |
|
| | | 8.__Transition.__When benefits are not available under this | | section, the commissioner may provide benefits under | | pharmaceutical benefits programs that were in effect on May 26, | | 2001. |
|
| | | Sec. B-2. Transfer of General Fund and Fund for a Healthy Maine funding. | | Notwithstanding any other provision of law, the Commissioner of | | Human Services is authorized to transfer appropriations from the | | General Fund and Other Special Revenue allocations from the Fund | | for a Healthy Maine legislatively authorized to the Department of | | Human Services for operation of the elderly low-cost drug program | | pursuant to the Maine Revised Statutes, Title 22, section 254. | | Transfers under this section are limited to transfers from the | | Medical Care - Payments to Providers program to the Elderly Low- | | cost Drug program as a separate program for budget purposes. | | Transfers under this section may be accomplished by financial | | order upon the recommendation of the State Budget Officer and | | approval of the Governor. |
|
| | | Sec. B-3. Transfer of Other Special Revenue funding. Notwithstanding any | | other provision of law, the Commissioner of |
|
| | | Human Services is authorized to transfer Other Special Revenue | | allocations legislatively authorized to the Department of Human | | Services for purposes of providing prescription drug benefits | | under the Healthy Maine Prescription Program under the Maine | | Revised Statutes, Title 22, section 258. Transfers under this | | section are limited to transfers from the Medical Care - Payments | | to Providers program to the Maine Rx Program under the Maine | | Revised Statutes, Title 22, section 2681. Transfers under this | | section may be accomplished by financial order upon the | | recommendation of the State Budget Officer and approval of the | | Governor. |
|
| | | Sec. B-4. Retroactivity. Section 1 of this Part applies retroactively | | to May 26, 2001. |
|
| | | Emergency clause. In view of the emergency cited in the preamble, | | this Act takes effect when approved. |
|
| | | APPROPRIATIONS/ALLOCATIONS |
|
| | | This bill increases the tax anticipation note authorization | | level from $30,000,000 to $100,000,000 and includes a General | | Fund appropriation of $5,000,000 in fiscal year 2001-02 for the | | Office of the Treasurer of State for the debt service payments | | related to a $100,000,000 tax anticipation note expected to be | | issued for fiscal year 2001-02. Interest earnings attributable | | to the tax anticipation note will increase General Fund revenue | | in fiscal year 2001-02 by approximately $5,000,000. |
|
| | | This bill also authorizes the Department of Human Services to | | transfer legislatively authorized prescription drug benefit | | funding by financial order. |
|
| | | These provisions are also included in Committee Amendment "A" | | to L.D. 855, the Part II budget. |
|
| | | Part A of this bill provides authority for the Treasurer of | | State to borrow in anticipation of taxes through tax anticipation | | note authority not to exceed $100,000,000. The bill also | | provides a General Fund appropriation to pay the debt service | | requirements in fiscal year 2001-02 from the use of tax | | anticipation note authority up to $100,000,000. The debt service | | requirements in fiscal year 2001-02 will be offset from increased | | General Fund revenue from investment income earnings estimated at | | $5,000,000 from the proceeds of the tax anticipation note | | authority. |
|
| | | Part B of this bill authorizes the expenditure of funding | | among pharmaceutical benefits programs administered by the | | Department of Human Services. |
|
|